Huffines Robert Luther

Huffines Robert Luther serves as a Director at Insulet Corp., a company focused on innovative diabetes management solutions. His recent disclosures, tracked through SEC Form 4 filings, highlight 17 public disclosures from July 12, 2024, to July 7, 2026, predominantly in the healthcare sector. Notable transactions include a significant grant/exercise action valued at approximately $23.3K related to Insulet Corp. (PODD) and multiple disclosures involving Walgreens Boots Alliance, Inc. (WBA) and Becton Dickinson and Co (BDX).